This multi-cohort analysis examines outcomes in early-life-acquired HIV, suggesting tailored interventions improve adherence and immune recovery.
Early ART initiation and tailored interventions are essential to optimize outcomes in ELHIV populations. PI-based regimens were a risk factor for VF, whereas integrase strand transfer inhibitors appeared protective. Adolescents and young adults require targeted support to improve adherence and immune recovery, aligning with UNAIDS goals.
No takes yet. Share an insight, caveat, or question.
Tarancon-Diez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: